Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuna Guo

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Molecular Cancer Therapeutics|July 25, 2015
R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and MetastasisYuna Guo, S Ray Kenney, Carolyn Y Muller, et al.
Chemistry, an Asian Journal|June 17, 2022
Mannose-targeting Concanavalin A-Epirubicin Conjugate for Targeted Intravesical Chemotherapy of Bladder CancerFan Huo, Yang Zhang, Yiran Li, et al.
Plos One|November 13, 2015
Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPasesTudor I Oprea, Larry A Sklar, Jacob O Agola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer PatientsYuna Guo, S Ray Kenney, Linda Cook, et al.
Plos One|August 7, 2015
A Pan-GTPase Inhibitor as a Molecular ProbeLin Hong, Yuna Guo, Soumik BasuRay, et al.
Gut|June 10, 2018
Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysisMing Yu, Sean K Maden, Matthew Stachler, et al.
ACS Chemical Biology|May 11, 2018
Activation of Rho Family GTPases by Small MoleculesCharuta C Palsuledesai, Zurab Surviladze, Anna Waller, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Molecular Cancer Therapeutics|July 25, 2015
R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and MetastasisYuna Guo, S Ray Kenney, Carolyn Y Muller, et al.
Chemistry, an Asian Journal|June 17, 2022
Mannose-targeting Concanavalin A-Epirubicin Conjugate for Targeted Intravesical Chemotherapy of Bladder CancerFan Huo, Yang Zhang, Yiran Li, et al.
Plos One|November 13, 2015
Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPasesTudor I Oprea, Larry A Sklar, Jacob O Agola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer PatientsYuna Guo, S Ray Kenney, Linda Cook, et al.
Plos One|August 7, 2015
A Pan-GTPase Inhibitor as a Molecular ProbeLin Hong, Yuna Guo, Soumik BasuRay, et al.
Gut|June 10, 2018
Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysisMing Yu, Sean K Maden, Matthew Stachler, et al.
ACS Chemical Biology|May 11, 2018
Activation of Rho Family GTPases by Small MoleculesCharuta C Palsuledesai, Zurab Surviladze, Anna Waller, et al.
Pageof 7